DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Intra-Cellular Therapies Inc. (ITCI)
« Back to company indexITCI Chatter Timeline
Stock Ticker for ITCI
Most Active Tweeters for ITCI
| User | Tweets |
|---|---|
| @bulletin_en | 14 |
| @reurope_stock | 10 |
| @thefinreviewer | 7 |
| @bibeypost_stock | 7 |
| @whatsonthorold2 | 7 |
Recent Tweets for ITCI
 |
@OlympiaReport Investors Buy Large Volume of Intra-Cellular Therapies Call Options $ITCI https://t.co/s2x5YacIj7 April 19th 2019, 2:04am |
 |
@WeekHerald Investors Buy Large Volume of Intra-Cellular Therapies Call Options $ITCI https://t.co/J7lvrRTWC1 April 19th 2019, 2:04am |
 |
@TickerReport Cantor Fitzgerald Reiterates “Buy” Rating for Intra-Cellular Therapies $ITCI https://t.co/fDqmdyCaYp April 19th 2019, 1:04am |
 |
@mchaudhry82 $ITCI Intra Cellular Therapies call volume above normal and directionally bullish https://t.co/vHyaiLtkVK April 18th 2019, 2:04pm |
 |
@bulletin_en Intra-cellular Therapies Inc $ITCI Big Money Q4 2018 Sentiment at 0.93 https://t.co/NZ58cVqrvl April 18th 2019, 1:04pm |
 |
@dakotafinancial Intra-Cellular Therapies $ITCI Receives “Buy” Rating from Cantor Fitzgerald https://t.co/cNDH8JRUts April 18th 2019, 11:04am |
 |
@stocknewstimes Investors Buy High Volume of Call Options on Intra-Cellular Therapies $ITCI https://t.co/fJuWujKYSx April 18th 2019, 7:04am |
 |
@TranscriptDaily Investors Buy High Volume of Call Options on Intra-Cellular Therapies $ITCI https://t.co/hMfR0MzQIT April 18th 2019, 6:04am |
 |
@registrarjourn Intra-Cellular Therapies Target of Unusually High Options Trading $ITCI https://t.co/ICZsJsAnjd April 18th 2019, 6:04am |
 |
@EnterpriseLeade Intra-Cellular Therapies Target of Unusually High Options Trading $ITCI https://t.co/USusk4GauN April 18th 2019, 6:04am |
 |
@AmericanBanking Intra-Cellular Therapies Target of Unusually High Options Trading $ITCI https://t.co/kONE3NELPT #stocks April 18th 2019, 6:04am |
 |
@dispatchtribune Intra-Cellular Therapies Target of Unusually High Options Trading $ITCI https://t.co/UdV0z6nmyr April 18th 2019, 6:04am |
 |
@UlmHi Contrasting of Sage Therapeutics Inc. $ITCI https://t.co/X6vj8Cmb5O April 18th 2019, 12:04am |
 |
@whatsonthorold2 Analysts See $-0.89 EPS for Intra-Cellular Therapies, Inc. $ITCI https://t.co/7gEBIe9HEu April 17th 2019, 7:04pm |
|
@bulletin_en Intra-Cellular Therapies, Inc. $ITCI EPS Estimated At $-0.89 as of May, 2 https://t.co/b4pMdvg2xx April 17th 2019, 7:04pm |
 |
@jschreiner75 RT @GrinderCapital: #UOA Activity Alert - $ITCI buyer of MAY17.5C (~8.1k contracts vs prior OI 450) - $EMN buyer of MAY80P (~2k contracts v… April 17th 2019, 12:04pm |
 |
@GrinderCapital #UOA Activity Alert - $ITCI buyer of MAY17.5C (~8.1k contracts vs prior OI 450) - $EMN buyer of MAY80P (~2k contrac… https://t.co/wFg7u0xzXZ April 17th 2019, 12:04pm |
 |
@thefinreviewer DBV Technologies S.A. $ITCI Comparing side by side https://t.co/xTqnHTRPhL April 17th 2019, 11:04am |
 |
@reurope_stock Are Analysts Bullish about Intra-Cellular Therapies, Inc. $ITCI after last week? https://t.co/d6QV9T3PHY April 17th 2019, 8:04am |
|
@stocknewstimes Intra-Cellular Therapies $ITCI Rating Reiterated by Cantor Fitzgerald https://t.co/MwNgwTl6ai April 17th 2019, 3:04am |
|
@TranscriptDaily Intra-Cellular Therapies $ITCI Earns “Buy” Rating from Cantor Fitzgerald https://t.co/JIhQFEoYbT April 17th 2019, 3:04am |
|
@whatsonthorold2 Intra-Cellular Therapies, Inc. $ITCI Analysts See $-0.89 EPS https://t.co/k7KlwHt7it April 16th 2019, 7:04pm |
 |
@bibeypost_stock Analysts See $-0.89 EPS for Intra-Cellular Therapies, Inc. $ITCI https://t.co/gm04UzOs8X April 16th 2019, 7:04pm |
|
@reurope_stock Intra-Cellular Therapies, Inc. $ITCI EPS Estimated At $-0.89 https://t.co/nucOyggNgn April 16th 2019, 7:04pm |
|
@bulletin_en Reviewing Anavex Life Sciences Corp. $ITCI's results https://t.co/0uGFcf2FkK April 16th 2019, 6:04pm |
|
@thefinreviewer Contrasting of Provention Bio Inc. $ITCI https://t.co/jPOh3e5L2l April 16th 2019, 6:04pm |
|
@UlmHi TRACON Pharmaceuticals Inc. $ITCI https://t.co/87RhPaNFiX April 16th 2019, 1:04am |
|
@bulletin_en Reviewing Zafgen Inc. $ITCI's results https://t.co/sXyN7zxJJE April 15th 2019, 7:04pm |
|
@bulletin_en Anticipated $-0.89 EPS for Intra-Cellular Therapies, Inc. $ITCI on May, 2 https://t.co/kSpiE86gMj April 15th 2019, 6:04pm |
 |
@mmahotstuff1 $-0.89 EPS Expected for Intra-Cellular Therapies, Inc. $ITCI https://t.co/VCe5dNlB5S April 15th 2019, 6:04pm |
|
@whatsonthorold2 Intra-Cellular Therapies, Inc. $ITCI Analysts See $-0.89 EPS https://t.co/3FYQt5TkjT April 15th 2019, 6:04pm |
|
@bibeypost_stock Intra-Cellular Therapies, Inc. $ITCI Analysts See $-0.89 EPS https://t.co/rAEZJz6TBS April 15th 2019, 6:04pm |
|
@reurope_stock Intra-Cellular Therapies, Inc. $ITCI Analysts See $-0.89 EPS https://t.co/E83560qcsO April 15th 2019, 6:04pm |
|
@thefinreviewer Xeris Pharmaceuticals Inc. $ITCI Contrasting side by side https://t.co/nL0eMvbV6s April 15th 2019, 5:04pm |
|
@bibeypost_stock Time to Reconsider Intra-cellular Therapies Inc $ITCI After More Short Sellers? https://t.co/5e1OJxNI2O April 15th 2019, 4:04pm |
|
@AmericanBanking Cantor Fitzgerald Reiterates Buy Rating for Intra-Cellular Therapies $ITCI https://t.co/ahYyQm91De #stocks April 15th 2019, 11:04am |
 |
@TheMarketsDaily Intra-Cellular Therapies $ITCI Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/qzNkwqVwcp April 15th 2019, 11:04am |
 |
@macondailynews Intra-Cellular Therapies’ $ITCI Buy Rating Reaffirmed at Cantor Fitzgerald https://t.co/rfJ4KiqSzz April 15th 2019, 11:04am |
|
@UlmHi Intra $ITCI Market Valuation Declined While Schroder Investment Management Group Has Trimmed Its Holding by $479,05… https://t.co/Smlc9hpeip April 15th 2019, 11:04am |
 |
@biotechhack One of the important papers of the greengard lab. $ITCI https://t.co/2p3t3dhEnz April 15th 2019, 10:04am |
 |
@Briefingcom $ITCI: Intra-Cellular Therapies announces additional results from its open-label safety switching study assessing... https://t.co/1ApH6pH5Vt April 15th 2019, 9:04am |
 |
@OpenOutcrier $ITCI (+0.0% pre) Intra-Cellular Therapies presents additional results on Lumateperone at 2019 Congress of SIRS https://t.co/6KZD0ANWU9 April 15th 2019, 8:04am |
 |
@ProTradersNews $ITCI: Intra-Cellular Therapies presents additional results on …: https://t.co/h59wc6pLng April 15th 2019, 8:04am |
 |
@MarketCurrents $ITCI - Intra-Cellular Therapies presents additional results on Lumateperone at 2019 Congress of SIRS https://t.co/0eucZcxEve April 15th 2019, 8:04am |
|
@biotechhack What a career, may he Rest in Peace. My condolences to all at $ITCI today as well. https://t.co/bSysNTry4r April 15th 2019, 7:04am |
 |
@MarketChmln $ITCI option volume was 3X normal on Friday with 7,041 contracts. Call volume was 11% and put volume was 89%. https://t.co/o8v6bqi5Z7 April 15th 2019, 2:04am |
|
@thefinreviewer Reviewing Cellular Biomedicine Group Inc. $ITCI's results https://t.co/0Q4cs5gdwf April 15th 2019, 1:04am |
|
@thefinreviewer Marinus Pharmaceuticals Inc. $ITCI https://t.co/muyUaE4iLU April 15th 2019, 12:04am |
|
@mmahotstuff1 Intra-Cellular Therapies, Inc. $ITCI EPS Estimated At $-0.89 https://t.co/NLEgUKX5Nz April 14th 2019, 8:04pm |
|
@whatsonthorold2 Intra-Cellular Therapies, Inc. $ITCI Analysts See $-0.89 EPS https://t.co/tMoldCGsGe April 14th 2019, 8:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.